<?xml version="1.0" encoding="UTF-8"?>
<p>Overall, these clinical studies have demonstrated that NoV VLP-based vaccine candidates produced in insect cells and plants are safe and immunogenic in humans. Since the model of NV infection in human volunteers has been established recently [
 <xref ref-type="bibr" rid="CR000840">40</xref>, 
 <xref ref-type="bibr" rid="CR0008150">150</xref>], the efficacy of adjuvanted NVCP VLP vaccines through IN and oral delivery should be further examined in this human challenge model.
</p>
